Hyperbaric Oxygen for Acute Ischemic Stroke:A Systematic Review of Randomized Controlled Trials

曹朝阳,刘鸣,谈颂
DOI: https://doi.org/10.3969/j.issn.1004-3594.2004.02.011
2004-01-01
Abstract:Objectives To assess the efficacy and safely of hyperbaric oxygen (HBO) in treatment of acute ischemic stroke(AIS). Methods A systematic review of world - wide literature on randomized controlled trials (RCTs) of HBO in treatment of AIS was performed by using Cochrane collaboration network, All unconfounded truly randomized trials or quasi-randomized trials (CCTs) completed before the end of 2001 were included. Results Twenty-three completed RCTs or CCTs were retrieved, of which 18 trials (including 2 040 patients) met the inclusion criteria. HBO was associated with a significant reduction in early deaths (0 vs 11%; odds ratio 0.12; 95% contidential interval 0.02 - 0.90; P = 0.04) .suggesting that treatment 1 of 9 patients would avoid early death. The adverse effects were significantly more in the HBO group than in the control group (2.82% vs0; OR5.54; 95% CI2.09- 14.68; P =0.0006). There were more patients in the HBO group who had neurologic defects improved at the end of treatment (94.88% vs 79.18%; OR4.37; 95% CI 3.30-5.77; P 0.001) .Conclusion HBO is a promising therapy for treatment of AIS. But as the trials included in the review were of poor methodological quality, we could not draw reliable conclusions from the present data. Rigorously designed, randomised, and controlled trials are required.
What problem does this paper attempt to address?